Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | News item

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance on the management of anaphylaxis in COVID-19 vaccination centres after two reports of anaphylaxis following immunisation with the Pfizer-BioNTech COVID-19 vaccine [Tozinameran] in the UK, and one report of possible allergic reaction, said Dr June Raine, Chief Executive of the MHRA.803524004 …
Literatur
1.
Zurück zum Zitat Medicines and Healthcare products Regulatory Agency. Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine. Internet Document : 9 Dec 2020. Available from: URL: https://www.gov.uk/government/news/confirmation-of-guidance-to-vaccinationcentres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine. Medicines and Healthcare products Regulatory Agency. Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine. Internet Document : 9 Dec 2020. Available from: URL: https://​www.​gov.​uk/​government/​news/​confirmation-of-guidance-to-vaccinationcentr​es-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine.​
2.
Zurück zum Zitat Health Canada. Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies. Internet Document : 12 Dec 2020. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/74543a-eng.php. Health Canada. Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies. Internet Document : 12 Dec 2020. Available from: URL: https://​healthycanadians​.​gc.​ca/​recall-alert-rappel-avis/​hc-sc/​2020/​74543a-eng.​php.​
Metadaten
Titel
Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-87824-3

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Lidocaine

Case report

Bleomycin